Correlation between MTHFR 677C > T polymorphism and response of pemetrexed-based chemotherapy in advanced NSCLC: A meta-analysis

Han Feng; Xu Wengui

doi:10.1515/pteridines-2020-0026

Pteridines (May 2021)

Correlation between MTHFR 677C > T polymorphism and response of pemetrexed-based chemotherapy in advanced NSCLC: A meta-analysis

Han Feng,
Xu Wengui

Affiliations

Han Feng: Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, People’s Republic of China
Xu Wengui: Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, People’s Republic of China

DOI: https://doi.org/10.1515/pteridines-2020-0026
Journal volume & issue: Vol. 32, no. 1
pp. 23 – 32

Abstract

Read online

The aim of this study was to investigate the correlation between MTHFR 677C > T polymorphism and response of pemetrexed-based chemotherapy in advanced non-small-cell lung cancer (NSCLC) by pooling the open published relevant studies.

Published in Pteridines

ISSN: 0933-4807 (Print); 2195-4720 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Science: Chemistry: Crystallography
Website: https://www.degruyter.com/view/j/pteridines

About the journal

Abstract

Keywords